...
首页> 外文期刊>Journal of neurotrauma >Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury.
【24h】

Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury.

机译:他汀类药物可增加齿状回中的神经发生,减少海马CA3区神经元的延迟死亡,并改善脑外伤后大鼠的空间学习。

获取原文
获取原文并翻译 | 示例
           

摘要

Traumatic brain injury (TBI) remains a major public health problem globally. Presently, there is no way to restore cognitive deficits caused by TBI. In this study, we seek to evaluate the effect of statins (simvastatin and atorvastatin) on the spatial learning and neurogenesis in rats subjected to controlled cortical impact. Rats were treated with atorvastatin and simvastatin 1 day after TBI and daily for 14 days. Morris water maze tests were performed during weeks 2 and 5 after TBI. Bromodeoxyuridine (BrdU; 50 mg/kg) was intraperitoneally injected 1 day after TBI and daily for 14 days. Brain tissue was processed for immunohistochemical staining to identify newly generated cells and vessels. Our data show that (1) treatment of TBI with statins improves spatial learning on days 31-35 after onset of TBI; (2) in the non-neurogenic region of the hippocampal CA3 region, statin treatment reduces the neuronal loss after TBI, demonstrating the neuroprotective effect of statins; (3) in the neurogenic region of the dentate gyrus, treatment of TBI with statins enhances neurogenesis; (4) statin treatment augments TBI-induced angiogenesis; and (5) treatment with simvastatin at the same dose provides a therapeutic effect superior to treatment with atorvastatin. These results suggest that statins may be candidates for treatment of TBI.
机译:创伤性脑损伤(TBI)仍然是全球范围内的主要公共卫生问题。目前,尚无办法恢复由TBI引起的认知缺陷。在这项研究中,我们寻求评估他汀类药物(辛伐他汀和阿托伐他汀)对受到皮质控制的大鼠的空间学习和神经发生的作用。 TBI后1天和每天14天分别用阿托伐他汀和辛伐他汀治疗大鼠。在TBI后的第2周和第5周进行了莫里斯水迷宫测试。 TBI后1天腹膜内注射溴脱氧尿苷(BrdU; 50 mg / kg),每天14天。对脑组织进行免疫组织化学染色以鉴定新产生的细胞和血管。我们的数据表明:(1)用他汀类药物治疗TBI可改善TBI发作后31-35天的空间学习; (2)在海马CA3区的非神经源性区域,他汀类药物治疗可减少TBI后的神经元丢失,证明他汀类药物的神经保护作用; (3)在齿状回的神经源性区域,用他汀类药物治疗TBI可增强神经发生。 (4)他汀类药物治疗可增强TBI诱导的血管生成; (5)以相同剂量的辛伐他汀治疗可提供优于阿托伐他汀治疗的治疗效果。这些结果表明他汀类药物可能是治疗TBI的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号